Equitable Access to High Cost Pharmaceuticals

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs Incorporates existing guidelines and recommendations by international organizations Compares and contrasts how different countries fund and police high-cost drug access Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing Reviews novel pharmaceuticals of current research interest

Produk Detail:

  • Author : Zaheer-Ud-Din Babar
  • Publisher : Academic Press
  • Pages : 238 pages
  • ISBN : 0128119624
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKEquitable Access to High Cost Pharmaceuticals

Equitable Access to High-Cost Pharmaceuticals

Equitable Access to High-Cost Pharmaceuticals
  • Author : Zaheer-Ud-Din Babar
  • Publisher : Academic Press
  • Release : 27 February 2018
GET THIS BOOKEquitable Access to High-Cost Pharmaceuticals

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies

Making Medicines Affordable

Making Medicines Affordable
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
  • Publisher : National Academies Press
  • Release : 01 March 2018
GET THIS BOOKMaking Medicines Affordable

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs

Price Setting and Price Regulation in Health Care

Price Setting and Price Regulation in Health Care
  • Author : OECD,World Health Organization,Barber Sarah L,Lorenzoni Luca,Ong Paul
  • Publisher : OECD Publishing
  • Release : 26 June 2019
GET THIS BOOKPrice Setting and Price Regulation in Health Care

The objectives of this study are to describe experiences in price setting and how pricing has been used to attain better coverage, quality, financial protection, and health outcomes. It builds on newly commissioned case studies and lessons learned in calculating prices, negotiating with providers, and monitoring changes. Recognising that no single model is applicable to all settings, the study aimed to generate best practices and identify areas for future research, particularly in low- and middle-income settings. The report and the

Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade

Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade
  • Author : World Intellectual Property Organization
  • Publisher : WIPO
  • Release : 16 May 2022
GET THIS BOOKPromoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.

Encyclopedia of Pharmacy Practice and Clinical Pharmacy

Encyclopedia of Pharmacy Practice and Clinical Pharmacy
  • Author : Anonim
  • Publisher : Academic Press
  • Release : 28 June 2019
GET THIS BOOKEncyclopedia of Pharmacy Practice and Clinical Pharmacy

Encyclopedia of Pharmacy Practice and Clinical Pharmacy covers definitions, concepts, methods, theories and applications of clinical pharmacy and pharmacy practice. It highlights why and how this field has a significant impact on healthcare. The work brings baseline knowledge, along with the latest, most cutting-edge research. In addition, new treatments, algorithms, standard treatment guidelines, and pharmacotherapies regarding diseases and disorders are also covered. The book's main focus lies on the pharmacy practice side, covering pharmacy practice research, pharmacovigilance, pharmacoeconomics, social and

Communities in Action

Communities in Action
  • Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Population Health and Public Health Practice,Committee on Community-Based Solutions to Promote Health Equity in the United States
  • Publisher : National Academies Press
  • Release : 27 April 2017
GET THIS BOOKCommunities in Action

In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also

Health Technology Assessment of Medical Devices

Health Technology Assessment of Medical Devices
  • Author : World Health Organization
  • Publisher : Who Medical Device Technical
  • Release : 25 October 2012
GET THIS BOOKHealth Technology Assessment of Medical Devices

WHO and partners have been working towards devising an agenda, an action plan, tools and guidelines to increase access to appropriate medical devices. This document is part of a series of reference documents being developed for use at the country level. The series will include the following subject areas: * policy framework for health technology * medical device regulations * health technology assessment * health technology management * needs assessment of medical devices * medical device procurement * medical equipment donations * medical equipment inventory management * medical equipment

How to Develop and Implement a National Drug Policy

How to Develop and Implement a National Drug Policy
  • Author : World Health Organization
  • Publisher : World Health Organization
  • Release : 16 May 2022
GET THIS BOOKHow to Develop and Implement a National Drug Policy

A drug policy is a crucial ingredient in every country's national health strategy as it provides a strategic framework to identify goals and commitments. This publication discusses the key components of such a policy. Issues covered include: the selection of essential drugs, affordability; finance and supply; regulation and quality assurance; rational use; research; human resources; monitoring and evaluation.

The Role of the Pharmacist in Patient Care

The Role of the Pharmacist in Patient Care
  • Author : Abdul Kader Mohiuddin
  • Publisher : Universal-Publishers
  • Release : 16 May 2022
GET THIS BOOKThe Role of the Pharmacist in Patient Care

The goal of a high quality, cost-effective and accessible health care for patients is achieved through constructing a team-based and patient-centered health care delivery system. The expanded role of pharmacists uplifts them to patient care from dispensing and manufacturing or marketing of drugs. Along with doctors and allied health professionals, pharmacists are increasingly recognized as an integral part of the patient care team. Furthermore, colleges of pharmacy need to revise and up-date their curricula to accommodate the progressively increasing development

Drug Safety in Developing Countries

Drug Safety in Developing Countries
  • Author : Yaser Mohammed Al-Worafi
  • Publisher : Academic Press
  • Release : 03 June 2020
GET THIS BOOKDrug Safety in Developing Countries

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug

Drugs and Money

Drugs and Money
  • Author : Maurice Nelson Graham Dukes
  • Publisher : IOS Press
  • Release : 16 May 2022
GET THIS BOOKDrugs and Money

This edition aims to provide policy makers and regulators with a compact and practical review of the various approaches that have been developed and tested to date in an effort to contain the overall costs of pharmaceutical services and drug treatment.

Ensuring Value for Money in Health Care

Ensuring Value for Money in Health Care
  • Author : Corinna Sorenson,Michael Drummond,Panos Kanavos
  • Publisher : WHO Regional Office Europe
  • Release : 16 May 2022
GET THIS BOOKEnsuring Value for Money in Health Care

This report addresses the concepts and controversy surrounding health technology assessment in Europe, with a particular focus on selected Member States including Sweden, the Netherlands, Finland, France, Germany and the United Kingdom. It is intended to identify and address current considerations regarding HTA methodological and process issues related to the prioritization and financing of modern health care. In particular, it describes the processes and challenges for identifying and prioritizing assessments; assesses and compares current assessment methods and procedures; and highlights

Access to Medicine in the Global Economy

Access to Medicine in the Global Economy
  • Author : Cynthia Ho
  • Publisher : Oxford University Press
  • Release : 21 April 2011
GET THIS BOOKAccess to Medicine in the Global Economy

Access to medicine is an important topic for all citizens of the world. While most people know that patents can increase the cost of medicine, important nuances of international laws that require nations to provide patents are frequently unknown or misunderstood. In Access to Medicine in the Global Economy, Professor Cynthia Ho introduces this issue to a diverse group of readers, including scholars, students and policy makers. While the focus of the book is the international arena, the book begins

Pharmaceutical Prices in the 21st Century

Pharmaceutical Prices in the 21st Century
  • Author : Zaheer-Ud-Din Babar
  • Publisher : Springer
  • Release : 05 December 2014
GET THIS BOOKPharmaceutical Prices in the 21st Century

This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.

A National Cancer Clinical Trials System for the 21st Century

A National Cancer Clinical Trials System for the 21st Century
  • Author : Institute of Medicine,Board on Health Care Services,Committee on Cancer Clinical Trials and the NCI Cooperative Group Program
  • Publisher : National Academies Press
  • Release : 08 July 2010
GET THIS BOOKA National Cancer Clinical Trials System for the 21st Century

The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.